Press "esc" to clear
Go to Advanced Search

Showing results

110 of 477

Article ID: 696348

Houston Methodist receives additional $6 million Occidental Petroleum donation to enhance community patient care

Houston Methodist

A Houston Methodist program that provides specialty patient care to uninsured and underserved patients received another multi-million dollar gift from Occidental Petroleum Corporation.

Released:
20-Jun-2018 8:30 AM EDT
EXPERT AVAILABLE
Open in New Tab
Comment
BassFamilyphoto2..jpg

Article ID: 696333

If Only…

Houston Methodist

The American Cancer Society's recent recommendations for changing the colorectal cancer screening age to 45 from age 50 had significant meaning for a Magnolia, Texas woman.

Released:
19-Jun-2018 3:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Comment

Article ID: 696082

MD Anderson, Houston Methodist Scientists Detect New Ovarian Cancer Target

Houston Methodist

Researchers at Houston Methodist Research Institute and The University of Texas MD Anderson Cancer Center have found a prescription drug, Calcitriol, approved by the Food and Drug Administration for the treatment of calcium deficiency and kidney diseases, may increase the likelihood of surviving ovarian cancer. Their preclinical research was reported in the Journal of the National Cancer Institute.

Released:
13-Jun-2018 1:00 PM EDT
EXPERT AVAILABLE
Open in New Tab
Comment

Article ID: 694865

Immune Cells Hold Promise in Slowing Down ALS

Houston Methodist

Recent research from Houston Methodist Hospital showed that a new immunotherapy was safe for patients with ALS and also revealed surprising results that could bring hope to patients who have this relentlessly progressive and fatal disease.

Released:
21-May-2018 10:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Comment
V1.3imageforNN-Chip.jpg
  • Embargo expired:
    9-May-2018 2:00 PM EDT

Article ID: 694247

Lab-on-a-Chip Device Mimics Eye Damage Due to Intense Light

Houston Methodist

Houston Methodist researchers developed a new lab-on-a-chip technology that could quickly screen possible drugs to repair damaged neuron and retinal connections, like what is seen in people with macular degeneration or who’ve had too much exposure to the glare of electronic screens.

Released:
8-May-2018 6:30 PM EDT
EXPERT AVAILABLE
Open in New Tab
Comment

Article ID: 692595

New Study Brings Hope to Liver Cancer Patients

Houston Methodist

Patients with cholangiocarcinoma, a form of liver cancer, were never candidates for liver transplant in the past. However, a new study looking at treating these patients with chemotherapy treatment first.

Released:
11-Apr-2018 11:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Comment

Article ID: 692554

Houston Methodist to Bring Successful Sepsis Reduction Program to Kingdom of Saudi Arabia

Houston Methodist

Houston Methodist Global Health Services is working with the Kingdom of Saudi Arabia and the Ministry of Health to decrease sepsis across the entire area.

Released:
10-Apr-2018 3:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Comment
Ashizawa_Tetsuo_DSC_3795a.jpg

Article ID: 692523

Houston Methodist Leads International Clinical Research for Rare Neurodegenerative Disorder

Houston Methodist

A rare, inherited neurodegenerative disorder will soon be the focus of an international clinical research effort led by Houston Methodist and funded by the National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health.

Released:
10-Apr-2018 11:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Comment
March2018CancerResearchjournal-Image.JPG
  • Embargo expired:
    22-Mar-2018 9:00 AM EDT

Article ID: 691537

Researchers Identify Compound That Prevents Breast Cancer Stem Cells From Activating in the Brain

Houston Methodist

Researchers at Houston Methodist used computer modeling to find an existing investigational drug compound for leukemia patients to treat triple negative breast cancer once it spreads to the brain.

Released:
21-Mar-2018 1:40 PM EDT
EXPERT AVAILABLE
Open in New Tab
Comment
RobertPhillipsresized.jpg
  • Embargo expired:
    7-Mar-2018 2:00 PM EST

Article ID: 690682

Renowned Cardiologist Says New Blood Pressure Guidelines Not Good for All

Houston Methodist

One of the nation’s leading cardiologists is challenging the new hypertension guidelines, perhaps sparing up to 10 million people from unnecessarily aggressive blood pressure treatments. His team’s study results appear March 7 in the Journal of the American College of Cardiology.

Released:
7-Mar-2018 1:00 AM EST
EXPERT AVAILABLE
Open in New Tab
Comment

Showing results

110 of 477





Chat now!